Efficacy and safety of tafamidis doses in the <scp>Tafamidis in Transthyretin Cardiomyopathy Clinical Trial</scp> ( <scp>ATTR‐ACT</scp> ) and long‐term extension studyThibaud Damy, Ronald Witteles, Balarama Gundapaneni et al.|European Journal of Heart Failure|2020Cited by 207